
This unique online CME course is designed for experienced clinicians who understand the basic therapeutic mechanisms of psychotropic medications and who are familiar with neurobiological and genetic contributions to psychiatric illnesses. World-renowned faculty focus on treatment of both typical and difficult-to treat child, adolescent, or geriatric psychiatric patients.
In Psychopharmacology — A Master Class, you’ll explore both the interface of medical and psychiatric disorders, and the interface between neurology and psychiatry. The importance of a therapeutic alliance when prescribing psychotropic medications is underscored, as are the hazards and benefits of polypharmacy drug interactions. Catch up on current and emerging treatments of:
Lecturer on Psychiatry
Harvard Medical School
Director, Continuing Education Program
Department of Psychiatry
Beth Israel Deaconess Medical Center
Professor of Psychiatry
Harvard Medical School
Professor of Psychiatry
Beth Israel Deaconess Medical Center
Professor of Psychiatry (Neuroscience)
Harvard Medical School
Director, Psychopharmacology Program
Director, International Consortium for Mood &
Psychotic Disorder Research
McLean Hospital
Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Chief, Division of Child and Adolescent Psychiatry
University of Miami Miller School of Medicine
Associate Professor of Psychiatry
Interim Chief, Section of Psychological Medicine
Director, Center for Well-being of Women and Mothers
Director, Adult Sickle Cell Program
Yale School of Medicine
Stanley Cobb Professor of Psychiatry
Department of Psychiatry
Harvard Medical School
Academic Head of Psychiatry
Department of Psychiatry
Beth Israel Deaconess Medical Center
Matthew P. Nemeroff Professor and Endowed Chair
Department of Psychiatry and Behavioral Sciences
Mulva Clinic for the Neurosciences
Director, Institute of Early Life Adversity Research
Dell Medical School
The University of Texas at Austin
Associate Professor of Psychiatry (part-time)
Harvard Medical School
Associate Professor of Psychiatry (part-time)
Beth Israel Deaconess Medical Center
Founding Chair Emeritus
Department of Neurology
Miriam Sydney Joseph Distinguished Professor
of Neurology
Harvard Medicine School
Kenneth T. Norris Jr. Professor
Department of Psychiatry and Behavioral Sciences
Stanford University
Distinguished University Health Professor Emeritus
University of South Florida College of Medicine
Professor of Psychiatry
University of California, San Diego
Honorary Visiting Senior Fellow
University of Cambridge, UK
Professor of Psychiatry
Harvard Medical School
Chief, Center of Excellence in Alcohol, Drugs,
and Addiction
Director, Alcohol, Drug, and Addiction Clinical
Research Program
McLean Hospital
Chief, Sleep Disorders Clinical Research Program
Departments of Psychiatry and Neurology
Massachusetts General Hospital
Professor of Psychiatry
Harvard Medical School
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Harvard Medical School designates this enduring material for a maximum of 14.00 AMA PRA Category 1
Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Original Release: May 15, 2021
Termination Date: January 31, 2024 (Please note that AMA PRA Category 1 Credits™ will no longer be issued for the activity after this date)
Estimated Time to Complete: 14.00 hours
CME credit is awarded upon successful completion of a course evaluation and post-test.
This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:
Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement.
Upon completion of this activity, participants will be better able to apply:
Experienced clinicians in the field of psychopharmacology drawn from the following disciplines: psychiatry, medicine, nursing, nurse practitioners, and psychology.
Provider: Harvard Medical School
Course Directors:
Lawrence E. Lifson, MD
Lecturer on Psychiatry
Harvard Medical School
Director, Continuing Education Program
Department of Psychiatry
Beth Israel Deaconess Medical Center
Carl Salzman, MD
Professor of Psychiatry
Harvard Medical School
Professor of Psychiatry
Beth Israel Deaconess Medical Center
Credits: Earn a maximum of 14.00 AMA PRA Category 1 Credits™
SKU: PSV456E0